Human Papillomavirus Clinical Trial
Official title:
Understanding HPV Vaccination Among Rural African American Primary Caregivers and Daughters
Verified date | August 2013 |
Source | University of Georgia |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
African American women living in the rural South are twice as likely as Caucasian women to
develop cervical cancer and die of invasive cervical cancer at a higher rate than any other
racial/ethnic group in the US (1). Reasons for low HPV vaccination rates among rural African
Americans are not well understood. HPV vaccination compliance is likely influenced by
barriers to health care access, misinformation regarding vaccinations, religious beliefs
related to sexual health and behaviors, and mistrust of the medical community (2, 3).
Because the vaccination of minors requires primary caregiver consent, vaccination commitment
and compliance is strongly influenced by family beliefs and communication regarding health
and sexuality. To date, little research has examined the cultural, familial, and
intrapersonal influences on HPV vaccination compliance among rural African American women.
This study will address these gaps in the literature and provide data needed to develop
effective interventions and health promotion materials to encourage HPV vaccination among
rural African American women.
From a pool of approximately 800 families who are participating in ongoing longitudinal
research through the Center for Family Research at the University of Georgia, the
investigators will recruit 200 rural female African American youth aged 13-17 who have not
received the HPV vaccine and their primary caregivers (n=200) into an observational,
prospective study on vaccination commitment and compliance. The investigators hypotheses are
as follows:
1. Sociocultural factors that rural African Americans experience, including
discrimination, previous health care experience, religious beliefs, and community norms
regarding HPV vaccination and adolescent sexual behavior, will forecast primary
caregivers' HPV vaccination commitment and compliance for their daughters. The
investigators also predict that primary caregivers' HPV-related knowledge and attitudes
will mediate this association.
2. Sociocultural factors will influence sexual health-related family communication and
interaction, primary caregivers' and youths' HPV-related attitudes, and HPV vaccination
commitment and compliance.
3. Primary caregivers' attitudes, youths' attitudes, and family health communication will
contribute to youths' and caregivers' vaccination commitment and compliance.
4. Youths' sexual behavior will influence their attitudes, family health communication,
and vaccination commitment and compliance.
Status | Completed |
Enrollment | 410 |
Est. completion date | July 2012 |
Est. primary completion date | April 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 13 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Rural African American girls aged 13-17 - Female parent or primary caregiver of participating daughter Exclusion Criteria: - Girls can not be younger than age 13, or older than 17 - The target's female parent or primary caregiver must also live in the same household and agree to participate |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | The Center for Family Research | Athens | Georgia |
Lead Sponsor | Collaborator |
---|---|
University of Georgia |
United States,
Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. Epub 2007 Jun 2. Review. — View Citation
Cates JR, Brewer NT, Fazekas KI, Mitchell CE, Smith JS. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health. 2009 Winter;25(1):93-7. doi: 10.1111/j.1748-0361.2009.00204.x. — View Citation
Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2007 Feb;109(2 Pt 1):360-70. Erratum in: Obstet Gynecol. 2007 Apr;109(4):1002. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HPV vaccination compliance | 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02740790 -
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
|
Phase 2 | |
Completed |
NCT01845779 -
Evaluation of Immune Response Against Human Papillomavirus (HPV)in Patients With Metastatic Cancer of the Anal Canal
|
N/A | |
Completed |
NCT01422356 -
Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men
|
N/A | |
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A | |
Completed |
NCT02808832 -
An HPV Vaccine Provider Intervention in Safety Net Clinics
|
N/A | |
Completed |
NCT01456715 -
Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.
|
Phase 3 | |
Completed |
NCT02968420 -
Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
|
Phase 4 | |
Completed |
NCT02007421 -
Study of the Prevention of Anal Cancer
|
N/A | |
Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
Completed |
NCT02267876 -
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
|
||
Recruiting |
NCT01459289 -
Psychosocial Effect of HPV Positivity
|
N/A | |
Completed |
NCT01358097 -
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
|
N/A | |
Completed |
NCT01342978 -
Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
|
N/A | |
Not yet recruiting |
NCT06434337 -
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
|
||
Active, not recruiting |
NCT02576561 -
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
|
Phase 2 | |
Terminated |
NCT02503111 -
The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men
|
N/A | |
Recruiting |
NCT02126189 -
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
|
N/A | |
Completed |
NCT01766284 -
Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix
|
N/A | |
Completed |
NCT01524003 -
Chinese Cancer Prevention Study(CHICAPS)
|
N/A | |
Recruiting |
NCT05026138 -
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
|